Biofrontera (BFRI) Gross Margin (2020 - 2026)
Biofrontera (BFRI) posted Gross Margin of 79.92% for Q2 2026, up 9.18 percentage points from 70.74% a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) Gross Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Biofrontera was 77.60%, up 18.58 percentage points year-over-year; for FY2025, it came in at 73.71%, up 23.57 percentage points from FY2024.
- Annual Gross Margin shows a four-year change of -24.13 percentage points (FY2021 to FY2025).
- In prior years, Biofrontera's Gross Margin was 50.14% in FY2024 (+1.34 pp), 48.80% in FY2023 (-49.22 pp), 98.02% in FY2022 (+0.18 pp) and 97.84% in FY2021.
- Quarterly Gross Margin has run from a low of -62.16% in Q4 2023 to a high of 99.42% in Q1 2023 over five years.
- On a year-over-year basis, Gross Margin increased in six of the last seven quarters, with an average year-over-year change of +23.66 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2024, with a gain of 120.19 percentage points; the weakest was Q4 2023, with a drop of 160.76 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.91 Bn | 1,101.50 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 615.07 Bn | 533.59 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 505.92 Bn | 479.03 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.25 Bn | 262.24 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.76 Bn | 235.45 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 236.19 Bn | 191.59 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 190.38 Bn | 164.57 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 170.37 Bn | 117.02 Bn | 10.94 Bn | 72.78% |
| 10 | Biofrontera | 10.34 Mn | -11.45 Mn | 9.59 Mn | 79.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.92% |
| Dec 31, 2025 | 82.40% |
| Sep 30, 2025 | 70.74% |
| Jun 30, 2025 | 70.74% |
| Mar 31, 2025 | 61.95% |
| Dec 31, 2024 | 58.03% |
| Sep 30, 2024 | 45.88% |
| Jun 30, 2024 | 44.61% |
| Mar 31, 2024 | 47.98% |
| Dec 31, 2023 | -62.16% |
| Sep 30, 2023 | 98.93% |
| Jun 30, 2023 | 98.02% |
| Mar 31, 2023 | 99.42% |
| Dec 31, 2022 | 98.60% |
| Sep 30, 2022 | 97.73% |
| Jun 30, 2022 | 96.59% |
| Mar 31, 2022 | 98.21% |
| Dec 31, 2021 | 98.03% |
| Sep 30, 2021 | 99.05% |
| Jun 30, 2021 | 97.69% |
API Access
Biofrontera Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();